Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Lacal

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Molecular and Cellular Biology|December 1, 1986
Activation of ras p21 transforming properties associated with an increase in the release rate of bound guanine nucleotideJ C Lacal, S A Aaronson
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1986
ras p21 deletion mutants and monoclonal antibodies as tools for localization of regions relevant to p21 functionJ C Lacal, S A Aaronson
Molecular and Cellular Biology|April 1, 1986
Monoclonal antibody Y13-259 recognizes an epitope of the p21 ras molecule not directly involved in the GTP-binding activity of the proteinJ C Lacal, S A Aaronson
Molecular and Cellular Biology|October 1, 1987
Expression of the Aplysia californica rho gene in Escherichia coli: purification and characterization of its encoded p21 productP S Anderson, J C Lacal
Journal of Cellular Biochemistry|April 1, 1994
ras-p21 activates phospholipase D and A2, but not phospholipase C or PKC, in Xenopus laevis oocytesA Carnero, F Dolfi, J C Lacal
Journal of Cellular Biochemistry|August 1, 1994
Progesterone but not ras requires MPF for in vivo activation of MAPK and S6 KII: MAPK is an essential conexion point of both signaling pathwaysA Carnero, B Jiménez, J C Lacal
Oncogene|December 21, 1995
Induction of apoptosis by rho in NIH 3T3 cells requires two complementary signals. Ceramides function as a progression factor for apoptosisP Esteve, L del Peso, J C Lacal
Cancer Research|July 9, 1999
In vivo antitumor activity of choline kinase inhibitors: a novel target for anticancer drug discoveryR Hernández-Alcoceba, F Fernández, J C Lacal
Nature|November 19, 1987
Novel source of 1,2-diacylglycerol elevated in cells transformed by Ha-ras oncogeneJ C Lacal, J Moscat, S A Aaronson
Biochemical and Biophysical Research Communications|June 30, 1989
Agonist-induced phosphorylation of an immunologically ras-related protein in human erythroleukemia cellsE R Lazarowski, J C Lacal, E G Lapetina
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Molecular and Cellular Biology|December 1, 1986
Activation of ras p21 transforming properties associated with an increase in the release rate of bound guanine nucleotideJ C Lacal, S A Aaronson
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1986
ras p21 deletion mutants and monoclonal antibodies as tools for localization of regions relevant to p21 functionJ C Lacal, S A Aaronson
Molecular and Cellular Biology|April 1, 1986
Monoclonal antibody Y13-259 recognizes an epitope of the p21 ras molecule not directly involved in the GTP-binding activity of the proteinJ C Lacal, S A Aaronson
Molecular and Cellular Biology|October 1, 1987
Expression of the Aplysia californica rho gene in Escherichia coli: purification and characterization of its encoded p21 productP S Anderson, J C Lacal
Journal of Cellular Biochemistry|April 1, 1994
ras-p21 activates phospholipase D and A2, but not phospholipase C or PKC, in Xenopus laevis oocytesA Carnero, F Dolfi, J C Lacal
Journal of Cellular Biochemistry|August 1, 1994
Progesterone but not ras requires MPF for in vivo activation of MAPK and S6 KII: MAPK is an essential conexion point of both signaling pathwaysA Carnero, B Jiménez, J C Lacal
Oncogene|December 21, 1995
Induction of apoptosis by rho in NIH 3T3 cells requires two complementary signals. Ceramides function as a progression factor for apoptosisP Esteve, L del Peso, J C Lacal
Cancer Research|July 9, 1999
In vivo antitumor activity of choline kinase inhibitors: a novel target for anticancer drug discoveryR Hernández-Alcoceba, F Fernández, J C Lacal
Nature|November 19, 1987
Novel source of 1,2-diacylglycerol elevated in cells transformed by Ha-ras oncogeneJ C Lacal, J Moscat, S A Aaronson
Biochemical and Biophysical Research Communications|June 30, 1989
Agonist-induced phosphorylation of an immunologically ras-related protein in human erythroleukemia cellsE R Lazarowski, J C Lacal, E G Lapetina
Pageof 8